Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).
Yazar
Wiland, P
Skinner, M
Dember, LM
Hauck, W
Garceau, D
Briand, R
Lachmann, H
Obici, L
Gorevic, PD
Hawkins, PN
Butrimiene, I
Lesnyak, O
Livneh, A
Filipowicz-Sosnowska, A
Merlini, G
DİRESKENELİ, RAFİ HANER
Benson, MD
Dispenzieri, A
GÜL, Ahmet
Hazenberg, BPC
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]